March 25 (Reuters) - Somnomed Ltd (SOM) :
- COVID 19 EXPECTED TO HAVE SIGNIFICANT BUT SHORT-TERM NEGATIVE IMPACT ON CO'S BUSINESS OF PROVIDING SOMNODENT ORAL APPLIANC
- CEO SALARY REDUCED BY 50% UNTIL FURTHER NOTICE
- DIRECTORS WILL FORGO ALL FEES UNTIL FURTHER NOTICE
- DECIDED TO REVOKE FY20 GUIDANCE AT THIS POINT IN TIME AND BELIEVES IT CANNOT PROVIDE AN UPDATED GUIDANCE DUE TO COVID 19
News: SOM Somnomed Says CEO Salary Reduced By 50% Until Further Notice
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
40.0¢ |
Change
0.030(8.11%) |
Mkt cap ! $86.44M | |||
| Open | High | Low | Value | Volume |
| 39.5¢ | 40.0¢ | 39.3¢ | $26.11K | 65.36K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 3990 | 38.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 40.0¢ | 159749 | 2 |
View Market Depth
| Last trade - 16.10pm 30/07/2024 (20 minute delay) ? |
| SOM (ASX) Chart |